Other genes containing recurrently hypomethylated promoters included TNFRSF10A (in five patients), encoding a TNF-related apoptosis-inducing ligand receptor that induces apoptosis [38], and MET (in three patients), a known oncogene implicated in NSCLC. The gene discussed is MET; the disease is non-small cell lung carcinoma.